CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-30 | Wigzell Hans Lennart Rudolf Director | Exercise or conversion | +6,667 | $7.38 | $49K | 13,333 |
| 2017-11-30 | Wigzell Hans Lennart Rudolf Director | Sale | −6,667 | $55.89 | $373K | 6,666 |
| 2017-11-30 | Wigzell Hans Lennart Rudolf Director | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −6,667 | $7.38 | $49K | 0 |
| 2017-11-08 | INGRAM DOUGLAS S President & CEO | Purchase | +38,138 | $52.44 | $2.0M | 420,196 |
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +10,000 | $14.76 | $148K | 37,045 |
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Sale | −10,000 | $55.00 | $550K | 27,045 |
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −10,000 | $14.76 | $148K | 31,144 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +11,500 | $14.76 | $170K | 38,545 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Sale | −11,500 | $50.00 | $575K | 27,045 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −11,500 | $14.76 | $170K | 41,144 |
| 2017-09-25 | Basi Guriqbal S. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +8,865 | 29,927 | ||
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Shares withheld for taxes | −2,882 | $37.88 | $109K | 27,045 |
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Restricted Stock Units | −8,865 | 0 | ||
| 2017-08-03 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +13,298 | 47,159 | ||
| 2017-08-03 | Mahatme Sandesh EVP, CFO & CBO | Shares withheld for taxes | −6,264 | $37.88 | $237K | 40,895 |
| 2017-08-03 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Restricted Stock Units | −13,298 | 0 | ||
| 2017-08-03 | Howton David T SVP, General Counsel | Exercise or conversion | +10,639 | 33,940 | ||
| 2017-08-03 | Howton David T SVP, General Counsel | Shares withheld for taxes | −4,642 | $37.88 | $176K | 29,298 |
| 2017-08-03 | Howton David T SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −10,639 | 0 |
Page 38 of 38 · 760 trades